Drug Metabolism and Therapeutics
- 20 March 1969
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 280 (12) , 653-660
- https://doi.org/10.1056/nejm196903202801210
Abstract
THE rapidly expanding number of therapeutic agents in use and the widespread administration of multiple medications to patients demand an increased awareness of both the metabolic effects of drugs and the possible effects of one drug on the metabolism of another. Studies during the past decade have shown dramatically that the duration and intensity of action of many drugs in animals depend on the activities of drug-metabolizing enzymes located primarily in the endoplasmic reticulum of the liver cell. These enzymes catalyze the metabolism of therapeutic agents by many pathways, such as hydroxylation, dealkylation, deamination, sulfoxidation, azo-link reduction and glucuronide formation. . . .Keywords
This publication has 15 references indexed in Scilit:
- REDUCTION IN CONCENTRATION OF TOTAL SERUM-BILIRUBIN IN OFFSPRING OF WOMEN TREATED WITH PHENOBARBITONE DURING PREGNANCYThe Lancet, 1968
- Cigarette Smoking: Stimulatory Effect on Metabolism of 3,4-Benzpyrene by Enzymes in Human PlacentaScience, 1968
- Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjectsMetabolism, 1967
- Enzyme Induction in Man caused by SmokingNature, 1967
- DICOUMAROL-INDUCED DIPHENYLHYDANTOIN INTOXICATIONThe Lancet, 1966
- APPLICATION OF DRUG METABOLISM TO DRUG TOXICITY STUDIESAnnals of the New York Academy of Sciences, 1965
- SULPHAPHENAZOLE-INDUCED HYPOGLYCÆMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICSThe Lancet, 1963
- Drug TolerancePublished by Wiley ,1962
- 461 Drugs as activators of drug enzymesBiochemical Pharmacology, 1961
- Studies on the metabolism of diphenylhydantoin (Dilantin)Neurology, 1961